Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$462M |
| 2 |
NVIDIA
NVDA
|
+$385M |
| 3 |
Meta Platforms (Facebook)
META
|
+$311M |
| 4 |
Apple
AAPL
|
+$301M |
| 5 |
EXE
Expand Energy Corp
EXE
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWN
Southwestern Energy Company
SWN
|
+$381M |
| 2 |
ExxonMobil
XOM
|
+$352M |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$223M |
| 4 |
VSTO
Vista Outdoor Inc.
VSTO
|
+$136M |
| 5 |
SoFi Technologies
SOFI
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 18.32% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Healthcare | 9.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Nortech Systems
NSYS
$40.4M
| $218K | ﹤0.01% |
20,020
-485
| -2% | -$5.5K |
|
3152
American Well
AMWL
$185M
| $217K | ﹤0.01% |
29,951
+779
| +3% | +$7.06K |
|
3153
Kentucky First Federal Bancorp
KFFB
$43.3M
| $217K | ﹤0.01% |
72,375
-1,549
| -2% | -$4.43K |
|
|
KZR
3154
DELISTED
Kezar Life Sciences
KZR
| $217K | ﹤0.01% |
+32,310
| New | +$241K |
|
3155
PepGen
PEPG
$127M
| $216K | ﹤0.01% |
57,102
+11,870
| +26% | +$74K |
|
3156
Turkcell
TKC
$4.78B
| $216K | ﹤0.01% |
33,150
+3,767
| +13% | +$24.5K |
|
3157
Jerash Holdings
JRSH
$57.5M
| $215K | ﹤0.01% |
62,920
+3,760
| +6% | +$12.1K |
|
|
BGFV
3158
DELISTED
Big 5 Sporting Goods
BGFV
| $214K | ﹤0.01% |
119,380
-109,163
| -48% | -$200K |
|
3159
Precision BioSciences
DTIL
$185M
| $211K | ﹤0.01% |
+55,475
| New | +$405K |
|
|
ENZ
3160
DELISTED
Enzo Biochem, Inc.
ENZ
| $211K | ﹤0.01% |
295,677
-8,815
| -3% | -$9.13K |
|
|
TSE
3161
DELISTED
Trinseo
TSE
| $210K | ﹤0.01% |
+41,224
| New | +$203K |
|
|
PPSI
3162
Pioneer Power Solutions
PPSI
$32.2M
| $205K | ﹤0.01% |
49,638
-9,451
| -16% | -$53.3K |
|
3163
Amylyx Pharmaceuticals
AMLX
$2.17B
| $205K | ﹤0.01% |
+54,114
| New | +$255K |
|
3164
Santander
BSBR
$41B
| $204K | ﹤0.01% |
52,212
+25,985
| +99% | +$119K |
|
3165
Natural Health Trends
NHTC
$15.6M
| $202K | ﹤0.01% |
43,760
+2,274
| +5% | +$12.3K |
|
3166
Mineralys Therapeutics
MLYS
$2.38B
| $202K | ﹤0.01% |
+16,412
| New | +$215K |
|
3167
Bilibili
BILI
$7.56B
| $200K | ﹤0.01% |
+11,045
| New | +$231K |
|
3168
Lightpath Technologies
LPTH
$651M
| $193K | ﹤0.01% |
54,543
| – | – |
|
3169
PMV Pharmaceuticals
PMVP
$58.7M
| $190K | ﹤0.01% |
126,004
| – | – |
|
3170
Air Industries Group
AIRI
$13.3M
| $190K | ﹤0.01% |
+46,721
| New | +$240K |
|
3171
Corbus Pharmaceuticals
CRBP
$168M
| $190K | ﹤0.01% |
16,075
| – | – |
|
3172
Flexible Solutions
FSI
$64.5M
| $190K | ﹤0.01% |
52,499
+11,017
| +27% | +$42.1K |
|
|
BMTX
3173
DELISTED
BM Technologies, Inc.
BMTX
| $188K | ﹤0.01% |
38,475
+8,175
| +27% | +$35.6K |
|
3174
Expensify
EXFY
$173M
| $187K | ﹤0.01% |
+55,629
| New | +$150K |
|
|
RDIB
3175
Reading International Class B
RDIB
$195M
| $185K | ﹤0.01% |
23,454
-329
| -1% | -$2.3K |
|
Similar funds
Dimensional Fund Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Dimensional Fund Advisors held 3,410 positions worth $416B, up 0.99% from $412B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 3.9%. Dimensional Fund Advisors opened 61 new positions and exited 71, leaving the 3,410-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2024 buy was Everus Construction Group: 1,833,827 shares worth $121M.
- Dimensional Fund Advisors added most to Merck in Q4 2024, an estimated $462M increase.
- Dimensional Fund Advisors's biggest Q4 2024 reduction was ExxonMobil, cutting an estimated $352M.
- Dimensional Fund Advisors fully exited Southwestern Energy Company in Q4 2024, selling an estimated $381M.
- Dimensional Fund Advisors's ten largest holdings make up 16% of its $416B portfolio in Q4 2024.
- Dimensional Fund Advisors opened 61 new positions and closed 71 in Q4 2024.
- Dimensional Fund Advisors's portfolio value rose 0.99% quarter-over-quarter to $416B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2024, filed 13 Feb 2025.